[HTML][HTML] T cell responses to SARS-CoV-2 spike cross-recognize Omicron
The SARS-CoV-2 Omicron variant (B.1.1.529) has multiple spike protein mutations 1 , 2 that
contribute to viral escape from antibody neutralization 3 , 4 , 5 – 6 and reduce vaccine …
contribute to viral escape from antibody neutralization 3 , 4 , 5 – 6 and reduce vaccine …
SARS-CoV-2 spike T cell responses induced upon vaccination or infection remain robust against Omicron
The SARS-CoV-2 Omicron variant has multiple Spike (S) protein mutations that contribute to
escape from the neutralizing antibody responses, and reducing vaccine protection from …
escape from the neutralizing antibody responses, and reducing vaccine protection from …
Author correction: T cell responses to SARS-CoV-2 spike cross-recognize omicron
… Tincho, 1, 2 Amkele Ngomti, 1, 2 Richard Baguma, 1, 2 Ntombi Benede, 1, 2 Akiko Suzuki,
1, 2 Khadija Khan, 3, 4 Sandile Cele, 3, 4 Mallory Bernstein, 3, 4 Farina Karim, 3, 4 Sharon V …
1, 2 Khadija Khan, 3, 4 Sandile Cele, 3, 4 Mallory Bernstein, 3, 4 Farina Karim, 3, 4 Sharon V …
[PDF][PDF] Rapid and focused maturation of a VRC01-class HIV broadly neutralizing antibody lineage involves both binding and accommodation of the N276-glycan
…, S Mohan, T Vollbrecht, O Kalyuzhniy, S Madzorera… - Immunity, 2019 - cell.com
The VH1-2 restricted VRC01-class of antibodies targeting the HIV envelope CD4 binding
site are a major focus of HIV vaccine strategies. However, a detailed analysis of VRC01-class …
site are a major focus of HIV vaccine strategies. However, a detailed analysis of VRC01-class …
HIV-1 glycan density drives the persistence of the mannose patch within an infected individual
…, SA Krumm, M Glaze, S Madzorera… - Journal of …, 2016 - Am Soc Microbiol
The HIV envelope glycoprotein (Env) is extensively modified with host-derived N-linked
glycans. The high density of glycosylation on the viral spike limits enzymatic processing, …
glycans. The high density of glycosylation on the viral spike limits enzymatic processing, …
[PDF][PDF] SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals
SI Richardson, VS Madzorera, H Spencer… - Cell Host & Microbe, 2022 - cell.com
The SARS-CoV-2 Omicron variant escapes neutralizing antibodies elicited by vaccines or
infection. However, whether Omicron triggers cross-reactive humoral responses to other …
infection. However, whether Omicron triggers cross-reactive humoral responses to other …
[HTML][HTML] Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanisms
…, P Kgagudi, NB Mzindle, R Ziki, S Madzorera… - Scientific Reports, 2022 - nature.com
Antibodies with the same variable region can exist as multiple isotypes with varying neutralization
potencies, though the mechanism for this is not fully defined. We previously isolated …
potencies, though the mechanism for this is not fully defined. We previously isolated …
[HTML][HTML] Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA. 1 and BA. 4 6 months after …
…, H Kaldine, CK Mukendi, VS Madzorera… - The Lancet Infectious …, 2023 - thelancet.com
Background COVID-19 vaccine rollout is lagging in Africa, where there has been a high rate
of SARS-CoV-2 infection. We aimed to evaluate the effect of SARS-CoV-2 infection before …
of SARS-CoV-2 infection. We aimed to evaluate the effect of SARS-CoV-2 infection before …
SARS-CoV-2 spike T cell responses induced upon vaccination or infection remain robust against Omicron (preprint)
The SARS-CoV-2 Omicron variant has multiple Spike (S) protein mutations that contribute to
escape from the neutralizing antibody responses, and reducing vaccine protection from …
escape from the neutralizing antibody responses, and reducing vaccine protection from …
Rapid and focused maturation of a VRC01-class broadly neutralizing antibody lineage involves both binding and accommodation of the N276-glycan
…, S Mohan, T Vollbrecht, O Kalyuzhniy, S Madzorera… - 2018 - papers.ssrn.com
The VH1-2 restricted VRC01-class of antibodies targeting the HIV Envelope CD4 binding
site (CD4bs) are a major focus of HIV vaccine strategies. While enormous progress has been …
site (CD4bs) are a major focus of HIV vaccine strategies. While enormous progress has been …